---
figid: PMC9257906__gr5
pmcid: PMC9257906
image_filename: gr5.jpg
figure_link: /pmc/articles/PMC9257906/figure/f0025/
number: Fig. 5
figure_title: ''
caption: 'Effects of BBR on pro-inflammatory cytokines of serum in mice (n = 8). A:
  CXCL9 content in the serum of each group mice; B: CXCL1 content in the serum of
  each group mice; C: IL-17 content in the serum of each group mice; D: TNF-αcontent
  in serum of each group mice. N.S: None statistically significant; ##P < 0.01 versus
  control group; ∗∗P < 0.01 versus UC group. &&P < 0.01 versus mesalazine group. BBR_Low:
  BBR with low dose; BBR_High: BBR with high dose.'
article_title: Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative
  colitis.
citation: Tao Yang, et al. Saudi Pharm J. 2022 Jun;30(6):764-778.
year: '2022'

doi: 10.1016/j.jsps.2022.03.015
journal_title: 'Saudi Pharmaceutical Journal : SPJ'
journal_nlm_ta: Saudi Pharm J
publisher_name: Elsevier

keywords:
- Ulcerative colitis
- Berberine
- IFN-γ
- Inflammation

---
